Page last updated: 2024-08-17

aniline and Neoplasms

aniline has been researched along with Neoplasms in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19909 (56.25)18.7374
1990's0 (0.00)18.2507
2000's4 (25.00)29.6817
2010's2 (12.50)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Barrabés, S; Carrión, MC; Castañeda, G; Cuevas, JV; Durá, G; Fernández-Aroca, DM; Jalón, FA; Leal, J; Manzano, BR; Martínez, MA; Massaguer, A; Rodríguez, AM; Ruiz-Hidalgo, MJ; Sánchez-Prieto, R; Santos, L1
Bai, YX; Qin, QP; Tan, MX; Wang, SL; Zou, BQ1
Ariga, K; Hill, JP; Hishita, S; Ishihara, S; Izawa, H; Ji, Q; Kawakami, K; Kosaki, Y; Krishnan, V; Shiratori, S; Sumita, M; Tateyama, Y; Vinu, A; Yamauchi, Y1
Chandrasekara Reddy, G; Chandregowda, V; Kush, AK1
Berger, DM; Chaudhary, I; Collins, K; Dutia, M; Feldberg, L; Floyd, MB; Kim, S; Mallon, R; Powell, D; Torres, N; Wojciechowicz, D1
TEMKIN, IS1
DIOGUARDI, N1
KAWAI, H1
KOROSTELEVA, TA1
WERTH, G1
LIPKIN, IL1
BAUER, KH1
DRUCKREY, H2
Ballard, P; Barlaam, BC; Bradbury, RH; Dishington, A; Hennequin, LF; Hickinson, DM; Hollingsworth, IM; Kettle, JG; Klinowska, T; Ogilvie, DJ; Pearson, SE; Scott, JS; Suleman, A; Whittaker, R; Williams, EJ; Wood, R; Wright, L1

Reviews

1 review(s) available for aniline and Neoplasms

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000

Other Studies

15 other study(ies) available for aniline and Neoplasms

ArticleYear
Effect of the aniline fragment in Pt(II) and Pt(IV) complexes as anti-proliferative agents. Standard reduction potential as a more reliable parameter for Pt(IV) compounds than peak reduction potential.
    Journal of inorganic biochemistry, 2021, Volume: 218

    Topics: A549 Cells; Aniline Compounds; Antineoplastic Agents; Apoptosis; Cell Proliferation; HCT116 Cells; Humans; MCF-7 Cells; Neoplasms; Organoplatinum Compounds; Platinum; Prodrugs

2021
Synthesis, Characterization, and Cytotoxicity of the Cobalt (III) Complex with N,N-Diethyl-4-(2,2':6',2''-terpyridin-4'-yl)aniline.
    Chemistry & biodiversity, 2018, Volume: 15, Issue:10

    Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cobalt; Coordination Complexes; Drug Screening Assays, Antitumor; G1 Phase Cell Cycle Checkpoints; Humans; Membrane Potentials; Mitochondria; Models, Molecular; Neoplasms

2018
Nanoporous carbon sensor with cage-in-fiber structure: highly selective aniline adsorbent toward cancer risk management.
    ACS applied materials & interfaces, 2013, Apr-24, Volume: 5, Issue:8

    Topics: Adsorption; Aniline Compounds; Biosensing Techniques; Carbon; Humans; Nanoparticles; Neoplasms; Porosity; Quartz

2013
Synthesis and in vitro antitumor activities of novel 4-anilinoquinazoline derivatives.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:7

    Topics: Aniline Compounds; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; ErbB Receptors; Gefitinib; Humans; Models, Molecular; Neoplasms; Phosphotransferases; Protein Structure, Tertiary; Quinazolines

2009
4-Anilino-7-alkenylquinoline-3-carbonitriles as potent MEK1 kinase inhibitors.
    Bioorganic & medicinal chemistry, 2008, Oct-15, Volume: 16, Issue:20

    Topics: Alkenes; Aniline Compounds; Animals; Cell Line, Tumor; Enzyme Activation; Humans; Inhibitory Concentration 50; Isoquinolines; MAP Kinase Kinase 1; Mice; Mice, Nude; Molecular Structure; Neoplasms; Nitriles; Protein Kinase Inhibitors; Structure-Activity Relationship; Substrate Specificity; Xenograft Model Antitumor Assays

2008
[Pathogenesis of occupational (aniline) tumors of the bladder].
    Sovetskaia meditsina, 1948, Volume: 12, Issue:2

    Topics: Aniline Compounds; Coloring Agents; Humans; Industry; Neoplasms; Occupational Diseases; Occupations; Urinary Bladder Neoplasms

1948
[Tumors of the urinary bladder and carcinogens].
    Rassegna internazionale di clinica e terapia, 1953, Aug-15, Volume: 33, Issue:15

    Topics: Aniline Compounds; Carcinogens; Coloring Agents; Neoplasms; Urinary Bladder Neoplasms

1953
[An autopsy case of aniline cancer].
    Gan, 1953, Volume: 44, Issue:2-3

    Topics: Aniline Compounds; Autopsy; Coloring Agents; Neoplasms

1953
[Precipitation method in detection of specific antigens created after orthoaminotoluol administration].
    Biulleten' eksperimental'noi biologii i meditsiny, 1956, Volume: 41, Issue:6

    Topics: Aniline Compounds; Antibodies; Antigens; Coloring Agents; Immune System Phenomena; Neoplasms

1956
[Production of tumors and disturbances in heredity pattern by experimental tissue anoxia].
    Arzneimittel-Forschung, 1958, Volume: 8, Issue:12

    Topics: Aniline Compounds; Animals; Coloring Agents; Heredity; Metabolism; Neoplasms; Neoplasms, Experimental

1958
PREVENTION OF OCCUPATIONAL CANCER OF THE URINARY BLADDER IN WORKERS IN ANILINE DYES INDUSTRY IN THE U.S.S.R.
    Acta - Unio Internationalis Contra Cancrum, 1963, Volume: 19

    Topics: Aniline Compounds; Carcinogens; Coloring Agents; Humans; Industry; Neoplasms; Occupational Diseases; Preventive Medicine; Toxicology; United States; Urinary Bladder Neoplasms; USSR

1963
[Chemistry and cancer; on aniline cancer (L. Rehn)].
    Langenbecks Archiv fur klinische Chirurgie ... vereinigt mit Deutsche Zeitschrift fur Chirurgie, 1950, Apr-11, Volume: 264

    Topics: Aniline Compounds; Neoplasms

1950
[Experimental cancer provoked by aniline and aniline-derivatives].
    Langenbecks Archiv fur klinische Chirurgie ... vereinigt mit Deutsche Zeitschrift fur Chirurgie, 1950, Apr-11, Volume: 264

    Topics: Aniline Compounds; Biochemical Phenomena; Biochemistry; Humans; Neoplasms

1950
[Pharmacology of cancerogenic substances; experiments with aniline].
    Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1950, Volume: 210, Issue:2

    Topics: Aniline Compounds; Humans; Neoplasms

1950
Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase.
    Bioorganic & medicinal chemistry letters, 2007, Nov-15, Volume: 17, Issue:22

    Topics: Administration, Oral; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Dogs; Drug Synergism; Mice; Molecular Structure; Neoplasms; Quinazolines; Rats; Receptor, ErbB-2; Triazoles; Xenograft Model Antitumor Assays

2007